Molecular Medicine
A section of Biomolecules (ISSN 2218-273X).
Section Information
The Section Molecular Medicine of the open access journal, Biomolecules (ISSN 2218-273X) publishes both high-impact areas of review articles and exceptional original research contributions. The areas of interest include but are not limited to molecular pathogenesis, molecular diagnosis and new therapeutical approaches, underpinning of human disorders, encompassing hereditary, neoplastic, metabolic, neurological, psychological, psychiatric, cardiovascular, immunological, renal, and infectious diseases. Research studies based on omics approaches are also welcome.
We invite you to submit your contributions focusing on but not restricted to:
We invite you to submit your contributions focusing on but not restricted to:
- Molecular pathogenesis
- Molecular diagnosis
- Molecular basis of diseases
- Experimental therapeutic approaches based on novel pathomechanisms
- Gene and protein networks regulating pathogenetic processes
- Epigenetic mechanisms regulating pathogenesis of human diseases
- Cellular signaling mechanisms regulating pathogenetic processes
- Systems biology approaches of molecular pathogenesis
- Bioinformatics and translational aspects of approaches of molecular pathogenesis
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Inflammatory Mechanisms and Molecular Targets in Neurological Disorders: Effects of Neuroprotective Drugs (Deadline: 30 July 2025)
- Role of Glutathione Peroxidase in Health and Disease (Deadline: 31 July 2025)
- Chronic Heart Failure: From Molecular Mechanisms to Therapies Strategies (Deadline: 31 July 2025)
- Exploring Novel Molecular Pathways and Emerging Treatments for Neuromuscular Disorders (Deadline: 31 July 2025)
- Molecular Advances in Inflammatory Bowel Disease (Deadline: 31 July 2025)
- Obesity-Related Diseases in Children: Molecular Basis and Therapeutic Approaches (Deadline: 31 July 2025)
- Cellular and Molecular Mechanisms in Cardiopathy and Therapeutic Strategies (Deadline: 31 July 2025)
- Recent Developments in Organometallic Syntheses for Biomedical Applications (Deadline: 31 July 2025)
- Artificial Intelligence (AI) in Biomedicine: 2nd Edition (Deadline: 31 July 2025)
- Focus on Perineural Invasion in Pancreatic Cancer (Deadline: 31 July 2025)
- TRP Channels in Cardiovascular and Inflammatory Disease, 2nd Edition (Deadline: 20 August 2025)
- The Role of CD36 in Human Health and Disease (Deadline: 31 August 2025)
- Diabetic Retinopathy: From Pathophysiology to Therapeutic Perspectives (Deadline: 31 August 2025)
- Diet and Immune Response (Deadline: 31 August 2025)
- Intracerebral Hemorrhage: Advances in Preclinical Studies: 2nd Edition (Deadline: 31 August 2025)
- Advances in Antiviral Drug Development (Deadline: 31 August 2025)
- Biomolecular Sciences and Precision Medicine in Vascular Disease (Deadline: 31 August 2025)
- Esophageal Diseases: Molecular Basis and Therapeutic Approaches (Deadline: 31 August 2025)
- Nerve Conduction Inhibition to Alleviate Disease Symptoms: Clinical Drugs and Medicinal Plant Compounds (Deadline: 31 August 2025)
- New Insights into Autacoids in Disease (Deadline: 31 August 2025)
- Heterocyclic Compounds as Novel Anti-Cancer Agents and Their Mechanisms of Action (Deadline: 31 August 2025)
- Molecular Insights into Treatment and Prognosis of Autoimmune Bullous Diseases (Deadline: 15 September 2025)
- Roles of Alpha-1 Antitrypsin in Human Health and Disease Models (Deadline: 15 September 2025)
- Dysregulated Cytokine Signals in Human Disease (Deadline: 25 September 2025)
- Diabetes, Overweight and Obesity: From Molecular Mechanisms to Therapies Strategies (Deadline: 30 September 2025)
- Recent Advances in the Role of Translation Machinery and Translational Control in the Cardiovascular System (Deadline: 30 September 2025)
- Health and Environmental Effect of Advanced Materials and Fine Particles: 2nd Edition (Deadline: 30 September 2025)
- Metabolic Syndrome and Type 2 Diabetes: From Molecular Pathogenesis to Novel Therapies (Deadline: 30 September 2025)
- Cell Death and Clearance (Deadline: 30 September 2025)
- Molecular Mechanisms and Therapeutic Targets in Leukaemia (Deadline: 30 September 2025)
- Pathogenesis and Neuropathology of Alzheimer's Disease (Deadline: 30 September 2025)
- Prebiotics and Probiotics in Health and Disease: Looking at the Future (Deadline: 30 September 2025)
- Breast Cancer: Molecular Pathology, Drug Resistance and Novel Treatment Strategies (Deadline: 30 September 2025)
- Lipids Metabolism in Cardiovascular Disease (Deadline: 30 September 2025)
- Redox Balance and Proteostasis Surveillance in Neurodegenerative Disorders (Deadline: 30 September 2025)
- Molecular Aspects of Diseases Origin and Development (Deadline: 30 September 2025)
- Molecular Mechanisms of Human Skin Aging (Deadline: 15 October 2025)
- Bioactive Molecules in the Control of Oxidative Stress and Oxidative Stress-Related Diseases (Deadline: 31 October 2025)
- Advancing Innovations in Biomedical Research for Translational Applications (Deadline: 31 October 2025)
- Advances in Metabolomics in Health and Disease (Deadline: 31 October 2025)
- Biomolecules and Materials Based Approaches in Biomedical Field: 2nd Edition (Deadline: 31 October 2025)
- Inflammation and Hemostasis: 2nd Edition (Deadline: 31 October 2025)
- New Insights into Kidney Disease Development and Therapy Strategies (Deadline: 31 October 2025)
- Nonalcoholic Fatty Liver Disease: From Molecular Mechanisms to Therapeutic Approaches (Deadline: 31 October 2025)
- Liver Damage and Associated Metabolic Disorders (Deadline: 31 October 2025)
- Ferroptosis and Cuproptosis: Mechanism and Crosstalk in Cancer, Neurodegeneration, and Metabolic Syndrome (Deadline: 31 October 2025)
- Notch and Its Regulation in Health and Disease (Deadline: 20 November 2025)
- New Insights into Cardiometabolic Diseases, 2nd Edition (Deadline: 30 November 2025)
- Thyroid Cancer: Molecular Mechanisms and Targeted Therapies (Deadline: 30 November 2025)
- Advances in Nano-Based Drug Delivery Systems (Deadline: 30 November 2025)
- Recent Advances in Cellular and Non-Cellular Treatment of Stroke (Deadline: 30 November 2025)
- Advances in Cancer and Glycosylation (Deadline: 30 November 2025)
- Mass Spectrometry Imaging in Neuroscience (Deadline: 30 November 2025)
- Advances in Type 2 Diabetes: Molecular Mechanisms and Therapeutic Innovations (Deadline: 30 November 2025)
- Multiple Sclerosis Pathogenesis: Bridging Innate and Adaptive Immunity (Deadline: 30 November 2025)
- Epstein-Barr Virus Disease Mechanisms and Stress Responses: 2nd Edition (Deadline: 15 December 2025)
- New Insights into Cardiovascular Immunology (Deadline: 15 December 2025)
- Novel Insights on Cancer Stem Cells (Deadline: 15 December 2025)
- Inflammatory Pathways in Heart Failure (Deadline: 30 December 2025)
- Advances in Melanoma Targeted Therapy (Deadline: 31 December 2025)
- Biomolecules in Myocarditis and Inflammatory Heart Disease (Deadline: 31 December 2025)
- Molecular Insights into Retinal Biology: Focus on Inflammation, Metabolism, and Retinal Dysfunction (Deadline: 31 December 2025)
- Cardiometabolic Disease: Molecular Basis and Therapeutic Approaches (Deadline: 31 December 2025)
- Molecular Basis of Pathogenesis in Autoimmune Diseases (Deadline: 31 December 2025)
- Biochemistry in Medicine—Honorary Special Issue Commemorating Research and Work of Professors Jan O. Aaseth and Jan Alexander (Deadline: 31 December 2025)
- Innate Immunomodulation and Inflammation: From Molecular Mechanisms to Pre-Clinical Insights (Deadline: 31 December 2025)
- Alcohol-Related Organ Damage: Mechanisms, Outcomes, and Treatment Modalities (Deadline: 31 December 2025)
- Tissue Calcification in Normal and Pathological Environments (Deadline: 31 December 2025)
- Neuron–Astrocyte Interactions in Neurological Function and Disease (Deadline: 31 December 2025)
- Molecular and Toxicological Profiling of Drugs of Abuse—in Honor of Professor Félix Carvalho (Deadline: 31 December 2025)
- New Insights into Molecular Mechanisms and Therapeutics for Malaria (Deadline: 31 December 2025)
- Signal Transduction to Transcription Factors in Health and Disease—Honorary Special Issue Commemorating the Work of Prof. Athanasios G. Papavassiliou (Deadline: 31 December 2025)
- Skeletal Muscle Homeostasis and Regeneration: 2nd Edition (Deadline: 15 January 2026)
- Pathogenesis and Targeted Therapy of Neurodegenerative Diseases (Deadline: 31 January 2026)
- Molecular Mechanisms, Novel Diagnostics and Treatments of Gynecologic Cancer (Deadline: 31 January 2026)
- Cellular and Molecular Basis of Parasite Infection (Deadline: 31 January 2026)
- Alcohol Consumption as a Cardiovascular Risk Factor: Focusing on Molecular Mechanisms (Deadline: 31 January 2026)
- Inositol Phosphates in Health and Disease, 2nd Edition (Deadline: 31 January 2026)
- New Insights into Mechanisms and Therapeutics for Cardiovascular Disorders: 2nd Edition (Deadline: 31 January 2026)
- Endometriosis: Molecular Pathogenesis and Translational Implications (Deadline: 31 January 2026)
- Pharmacology of Cardiovascular Diseases (Deadline: 31 January 2026)
- Developmental Biology of the Kidney: From Molecular Mechanisms to Congenital Disorders (Deadline: 31 January 2026)
- Molecular and Cellular Mechanisms in Anti-Thrombosis (Deadline: 28 February 2026)
- Novel Antimicrobial Strategies for Animal Health (Deadline: 31 March 2026)
- Bench and Bedside: Molecular Insights and Neuroprotective Strategies for Stroke (Deadline: 31 May 2026)
- Molecular Pathology, Diagnostics, and Therapeutics of Lung Disease (Deadline: 30 June 2026)
Topical Collections
Following topical collections within this section are currently open for submissions:
- Drug-Phototherapy (Closed)
- Emerging Targets and Tissue Engineering Strategies for Repair and Regeneration (Closed)
- Feature Papers in Section 'Molecular Medicine'
- Metabolomics and Integrated Multi-Omics in Health and Disease
- Natural and Synthetic Compounds in Neurodegenerative Disorders (Closed)
- Recent Advances in Cancer Immunotherapy
- Recent Advances in Pancreatic Cancer (Closed)
